Abstract

BackgroundThe Ras Association Domain Family Member 1 (RASSF1) is one of the most frequently reported methylation-inactivated tumor suppressor genes in primary pancreatic ductal adenocarcinomas (PDAC). Limited information is still available about the impact of RASSF1 gene silencing on the expression of its different isoforms in neoplastic cells.MethodsA series of 96 primary PDAC, with known clinico-pathological parameters, was tested for RASSF1 methylation status by methylation-specific PCR, RASSF1 locus copy number alterations by fluorescence in situ hybridization, and Rassf1a protein expression by immunohistochemistry. A further series of 14 xenografted primary PDAC and 8 PDAC-derived cell lines were tested to obtain a detailed methylation mapping of CpG islands A and C of the RASSF1 locus by pyrosequencing and to evaluate the expression of Rassf1 variants by qRT-PCR.ResultsMethylation of CpG island A of the RASSF1 gene was observed in 35 % of the tumors and allelic loss of RASSF1 locus was seen in 30 disomic and in 20 polysomic cases (52 %). Rassf1a immunohistochemical expression was downregulated in half of primary PDAC, and this downregulation was neither correlated with methylation of RASSF1 promoter nor with RASSF1 copy number alterations. RASSF1 status did not influence patients’ prognosis. The expression of the seven RASSF1 isoforms in xenografts and cell lines showed that RASSF1A, RASSF1B, and RASSF1C isoforms were present in all xenografts and cell lines, whereas RASSF1D, RASSF1E, and RASSF1F isoforms were variably expressed among samples. RASSF1G was never expressed in either xenografts or cell lines. The variable expression of RASSF1 isoforms in PDAC xenografts and cell lines was not dependent on RASSF1 methylation status of CpG islands A and C.ConclusionsRASSF1 alterations occurring in PDAC mainly consist in variations of expression of the different isoforms. Different genetic mechanisms seem to contribute to RASSF1 deregulation in this setting, but RASSF1 methylation does not seem to substantially affect RASSF1 isoforms expression.Electronic supplementary materialThe online version of this article (doi:10.1186/s12885-016-2048-0) contains supplementary material, which is available to authorized users.

Highlights

  • The Ras Association Domain Family Member 1 (RASSF1) is one of the most frequently reported methylation-inactivated tumor suppressor genes in primary pancreatic ductal adenocarcinomas (PDAC)

  • We report the evaluation of 96 primary PDAC for Rassf1a protein immunohistochemical expression, RASSF1 gene copy number by fluorescence in situ hybridization (FISH), and methylation of RASSF1 locus by methylation-specific PCR

  • Rassf1a immunohistochemical expression is downregulated in half of primary PDAC Rassf1a expression was evaluated by IHC in 10 normal pancreas, 96 primary PDAC tissues, 14 PDAC xenografts and 8 PDAC cell line

Read more

Summary

Introduction

The Ras Association Domain Family Member 1 (RASSF1) is one of the most frequently reported methylation-inactivated tumor suppressor genes in primary pancreatic ductal adenocarcinomas (PDAC). A recent genome-wide profiling of DNA methylation of 167 pancreatic ductal adenocarcinomas (PDAC) identified 3522 genes that showed an altered methylation status [1] Among these genes, the Ras Association Domain Family Protein 1 (RASSF1) locus showed frequent hypermethylation, confirming a previous report of RASSF1 locus hypermethylation in two thirds of primary PDAC and seven of eight PDAC cell lines [2]. As constituent of RAS/PI3K/AKT, RAS/RAF/MEK/ERK and Hippo cancer pathways, an important role in solid tumors has been suggested [12,13,14] and, in this context, RASSF1 is one of the most frequently reported methylation-inactivated tumor suppressor genes [12, 15]. Among the remaining RASSF1 variants, only RASSF1F was tested and found frequently expressed in PDAC cell lines [2]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.